T·B·B·T
ResearchSemiconductorsNASDAQ NMS - GLOBAL MARKETFull dossier
$109.95-2.71%as of 1:19 PM ET

INTCIntel Corporation

Semiconductor company; developed Horse Ridge cryo-CMOS controller ASIC (Horse Ridge I 2019 on Intel 22nm FDSOI, Horse Ridge II 2022 on Intel 10nm SuperFin) for scalable qubit control at 4K; also has silicon spin qubit research program.

Coiled

21

52w range compression, breakout-adjusted

Watched

100

7-day news volume + tape quietness

Sound

27

Margins, growth, FCF composite

Critical

92

Supply-chain concentration × demand

Pressure

59

Pricing Power

35.4%

Inflating

Financials

Numbers on the wire.

Market cap

$568.0B

P/E (TTM)

P/S (TTM)

9.23

EV / EBITDA

Gross margin

35.43%

Op margin

0.69%

Net margin

-5.90%

FCF margin

Rev growth YoY

1.36%

EPS growth YoY

ROE

-2.95%

ROA

-1.56%

Debt / Equity

0.40

Current ratio

2.31

Price / Book

1.86

Beta

2.21

Source: Finnhub. TTM = trailing twelve months.

Supply Chain

Layer Presence.

Our take

Intel's Horse Ridge cryo-CMOS chip is the most advanced public cryo-CMOS development for quantum control. Both Horse Ridge generations are internal R&D programs fabbed on Intel's own process nodes — NOT commercial products and NOT fabbed at TSM. Intel also has a silicon spin qubit research program (Si-28 enriched substrate). Both programs are internal-only. Risk: Intel's financial difficulties (2024-25 restructuring) may deprioritize quantum R&D.

Recent filings

From the EDGAR wire.

News

From the tape.